Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models

被引:94
|
作者
Kulak, Anita [1 ]
Steullet, Pascal [1 ]
Cabungcal, Jan-Harry [1 ]
Werge, Thomas [2 ]
Ingason, Andres [2 ]
Cuenod, Michel [1 ]
Do, Kim Quang [1 ]
机构
[1] Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Prilly, Switzerland
[2] Copenhagen Univ Hosp, Res Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, Roskilde, Denmark
基金
瑞士国家科学基金会;
关键词
N-ACETYL-CYSTEINE; LIGASE MODIFIER SUBUNIT; MAGNETIC-RESONANCE-SPECTROSCOPY; GLUTATHIONE-DEFICIENT MICE; DOPAMINE UPTAKE INHIBITION; ANTERIOR CINGULATE CORTEX; PITUITARY-ADRENAL AXIS; TERM SPATIAL MEMORY; PREFRONTAL CORTEX; PREPULSE INHIBITION;
D O I
10.1089/ars.2012.4858
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Schizophrenia (SZ) and bipolar disorder (BD) are classified as two distinct diseases. However, accumulating evidence shows that both disorders share genetic, pathological, and epidemiological characteristics. Based on genetic and functional findings, redox dysregulation due to an imbalance between pro-oxidants and antioxidant defense mechanisms has been proposed as a risk factor contributing to their pathophysiology. Recent Advances: Altered antioxidant systems and signs of increased oxidative stress are observed in peripheral tissues and brains of SZ and BD patients, including abnormal prefrontal levels of glutathione (GSH), the major cellular redox regulator and antioxidant. Here we review experimental data from rodent models demonstrating that permanent as well as transient GSH deficit results in behavioral, morphological, electrophysiological, and neurochemical alterations analogous to pathologies observed in patients. Mice with GSH deficit display increased stress reactivity, altered social behavior, impaired prepulse inhibition, and exaggerated locomotor responses to psychostimulant injection. These behavioral changes are accompanied by N-methyl-D-aspartate receptor hypofunction, elevated glutamate levels, impairment of parvalbumin GABA interneurons, abnormal neuronal synchronization, altered dopamine neurotransmission, and deficient myelination. Critical Issues: Treatment with the GSH precursor and antioxidant N-acetylcysteine normalizes some of those deficits in mice, but also improves SZ and BD symptoms when given as adjunct to antipsychotic medication. Future Directions: These data demonstrate the usefulness of GSH-deficient rodent models to identify the mechanisms by which a redox imbalance could contribute to the development of SZ and BD pathophysiologies, and to develop novel therapeutic approaches based on antioxidant and redox regulator compounds. Antioxid. Redox Signal. 18, 1428-1443.
引用
收藏
页码:1428 / 1443
页数:16
相关论文
共 50 条
  • [41] Actin Cytoskeleton Dysregulation in Schizophrenia and Bipolar Disorder: Relevance to Dendritic Spine Pathology
    Konopaske, Glenn
    Subburaju, Sivan
    Coyle, Joseph T.
    Benes, Francine M.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S341 - S341
  • [42] Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder
    Abdolmaleky, Hamid Mostafavi
    Yaqubi, Sahab
    Papageorgis, Panagiotis
    Lambert, Arthur W.
    Ozturk, Sait
    Sivaraman, Vadivelu
    Thiagalingam, Sam
    SCHIZOPHRENIA RESEARCH, 2011, 129 (2-3) : 183 - 190
  • [43] Animal Models of Bipolar Disorder: Genetic and Epigenetic Effects
    Petryshen, Tracey
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 288S - 288S
  • [44] Proteomics analysis of new animal models of bipolar disorder
    Ageta, Hiroshi
    Inokuchi, Kaoru
    Tsuchida, Kunihiro
    NEUROSCIENCE RESEARCH, 2010, 68 : E431 - E432
  • [45] Probiotics in autism spectrum disorder: Recent insights from animal models
    Golbaghi, Navid
    Naeimi, Saeideh
    Darvishi, Afra
    Najari, Niloofar
    Cussotto, Sofia
    AUTISM, 2024, 28 (11) : 2722 - 2737
  • [46] Distinguishing disruptive mood dysregulation disorder from pediatric bipolar disorder
    Noller, Diana T.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (06): : 25 - 28
  • [47] Developing translational animal models for symptoms of schizophrenia or bipolar mania
    Mark A. Geyer
    Neurotoxicity Research, 2008, 14 : 71 - 78
  • [48] Genetic Redox Dysregulation Induces Behavioural Deficits in the Adult Mouse: An Animal Model for Schizophrenia
    Frank, A.
    Dalton, T.
    Chen, Y.
    Cuenod, M.
    Do, K. Q.
    NEUROPSYCHOBIOLOGY, 2009, 59 (02) : 61 - 61
  • [49] Developing translational animal models for symptoms of schizophrenia or bipolar mania
    Geyer, Mark A.
    NEUROTOXICITY RESEARCH, 2008, 14 (01) : 71 - 78
  • [50] Translational research in bipolar disorder: emerging insights from genetically based models
    G Chen
    I D Henter
    H K Manji
    Molecular Psychiatry, 2010, 15 : 883 - 895